XBiotech (XBIT) IPO Opens Up 21%

Today's IPO for XBiotech Inc., (Nasdaq: XBIT) opened for trading at $23 after pricing 4,000,000 shares of its common stock at an initial public offering price of $19.00 per share.

WR Hambrecht + Co is acting as the sole underwriter for the offering.

XBiotech is a leading developer of next-generation therapeutic antibodies. The Company is also innovating with manufacturing technology and clinical strategies to lessen capital requirements and reduce lead times for drug development.

You May Also Be Interested In

• Scribe Therapeutics files for proposed Nasdaq IPO
• Sandwich chain Jersey Mike's looks to public markets with US IPO filing
• InvestorNewsBreaks – Alpex Acquisition Corporation (NASDAQ: ALPXU) Closes $115 Million Initial Public Offering